| Home | Log In | Register | Our Services | My Account | Contact | Help |
You are NOT currently logged in
Register now or login to post to this thread.
Mediwatch (MDW)
Janus
- 22 Jan 2004 08:19
Anybody follow this one ?
Janus
- 22 Jan 2004 11:15
- 2 of 145
LONDON (AFX) - Shares in Mediwatch continued to respond to recent news that
the company has gleaned marketing approval from the US Food and Drug
Administration (FDA) for the Portascan portable bladder scanner in the US.
The state-of-the-art portable diagnostic will be used to screen patients
suffering from prostate and bladder disorders, incontinence and those requiring
catheterization.
The group, whose shares were 3.00 pence higher at 10.87 by 8.30 am, is in
advanced stages to conclude a distribution agreement with a large,
well-established international company that is already selling into closely
related markets.
the company has gleaned marketing approval from the US Food and Drug
Administration (FDA) for the Portascan portable bladder scanner in the US.
The state-of-the-art portable diagnostic will be used to screen patients
suffering from prostate and bladder disorders, incontinence and those requiring
catheterization.
The group, whose shares were 3.00 pence higher at 10.87 by 8.30 am, is in
advanced stages to conclude a distribution agreement with a large,
well-established international company that is already selling into closely
related markets.
ELLIE - 22 Jan 2004 11:47 - 3 of 145
ELLIE - 22 Jan 2004 11:48 - 4 of 145
Any ideas on how much higher price might go - should I take profits or enjoy the ride for a bit longer?
SueHelen
- 22 Jan 2004 12:26
- 5 of 145
Hi Ellie,
I have myself bought some of these this morning at 10.15 pence.
Current Price 10.5 - 11.25 pence.
Feel these could follow the same pattern as ZIM and get past 20 pence + in the short term.
I have myself bought some of these this morning at 10.15 pence.
Current Price 10.5 - 11.25 pence.
Feel these could follow the same pattern as ZIM and get past 20 pence + in the short term.
SueHelen
- 22 Jan 2004 12:27
- 6 of 145
Record volume today for this stock with some very heavy buying reported.
SueHelen
- 22 Jan 2004 12:28
- 7 of 145
LONDON (AFX) - Shares in Mediwatch continued to respond to recent news that
the company has gleaned marketing approval from the US Food and Drug
Administration (FDA) for the Portascan portable bladder scanner in the US.
The state-of-the-art portable diagnostic will be used to screen patients
suffering from prostate and bladder disorders, incontinence and those requiring
catheterization.
The group, whose shares were 3.00 pence higher at 10.87 by 8.30 am, is in
advanced stages to conclude a distribution agreement with a large,
well-established international company that is already selling into closely
related markets.
the company has gleaned marketing approval from the US Food and Drug
Administration (FDA) for the Portascan portable bladder scanner in the US.
The state-of-the-art portable diagnostic will be used to screen patients
suffering from prostate and bladder disorders, incontinence and those requiring
catheterization.
The group, whose shares were 3.00 pence higher at 10.87 by 8.30 am, is in
advanced stages to conclude a distribution agreement with a large,
well-established international company that is already selling into closely
related markets.
SueHelen
- 22 Jan 2004 12:28
- 8 of 145
I am holding now for an early target of 20-25p which WILL happen on the announcement for the distribution agreement, tomorrow or early next week is my guess.
SueHelen
- 22 Jan 2004 12:32
- 9 of 145
SueHelen
- 22 Jan 2004 12:33
- 10 of 145
The FDA approval will be the catalyst for major announcement re US distribution deal: it is overdue. How high it goes thereafter is intriguing - I will suggest that we will see MDW over 25p short term and much higher long term.
ELLIE - 22 Jan 2004 12:40 - 11 of 145
Having originally bought in at 24p I've had a long wait, however also bought in at 3p so may break even/make profit soon. Fingers crossed!
SueHelen
- 22 Jan 2004 12:58
- 12 of 145
Delayed BUYS at 10.75 pence are coming through at the moment from an hour ago. Normal Market Size is only 3,000 so trades roughly over 18,000 shares are delayed in reporting by an hour.
SueHelen
- 22 Jan 2004 13:04
- 13 of 145
Delayed buys at 11 pence starting to come through.
100,000 BUY just been reported at 11 pence.
100,000 BUY just been reported at 11 pence.
SueHelen
- 22 Jan 2004 14:05
- 14 of 145
A superb, ground breaking medical product, has gained FDA approval for the huge USA market and the market capitalisation of this share is still only 6m at the start of play today !
Baring in mind the size of the market that Mediwatch is now about to dominate, it puts the shares on a very, very cheap valuation as they stand today.
They look very good for significant price MULIPLICATION for some time yet :
As a comparison, ZI Medical had a mediocre product released to the small UK market which it admitted it was "unsure of how much it would conribute to revenues". Yet the price has gone from 4p to in excess of 30p in about two weeks. Mediwatch stated expected revenue PER YEAR of $20m from the US alone.
It values ZI Medical at a mkt cap of 28m yet we are at a tiddly 6m mkt cap with a far greater product and far greater earnings visbility, and a far greater expected earnings amount. Therefore, Mediwatch shares are still undervalued by at least a MULIPLE of 3. A market cap of 30m would be a very conservative estimate of what Mediwatch should be on, and probably 50m is what Mediwatch deserves at this stage. Yet its valued at 6m !
That gives us a realistic price muliplication of 8 x 6m = 48m mkt cap. So 8 x 11p (share price) = 88p before it looks fully valued.
A MULIPLE OF 8 TIMES THE EXISTING SARE PRICE IS REALISTIC when compared to other firms who trade on 4/5 times next years full year revenues (if its a growth company and Mediwatch certainly is).
PLUS TWO FACTORS TO LOOK FORWARD TO :
- Mediwatch in advanced talks with a major and significant US distributor company for its product. As confirmed on the AFX statement out today. So a nice big RNS announcement is due within weeks.
- Press coverage. As yet it hasn't had much - but Investors Chronicle is out tommorrow and may cover the FDA announcement that came out from Mediwatch on Tuesday. If its not in this weeks Investors Chron (as too late to appear in thsi weeks edition) its sure to make next weeks.
Good pubilicity.
Plenty to look forward to - not least a more realistic mkt cap valuation. 6m is just way, way undervalued, and simultaneously, so is the share price.
Baring in mind the size of the market that Mediwatch is now about to dominate, it puts the shares on a very, very cheap valuation as they stand today.
They look very good for significant price MULIPLICATION for some time yet :
As a comparison, ZI Medical had a mediocre product released to the small UK market which it admitted it was "unsure of how much it would conribute to revenues". Yet the price has gone from 4p to in excess of 30p in about two weeks. Mediwatch stated expected revenue PER YEAR of $20m from the US alone.
It values ZI Medical at a mkt cap of 28m yet we are at a tiddly 6m mkt cap with a far greater product and far greater earnings visbility, and a far greater expected earnings amount. Therefore, Mediwatch shares are still undervalued by at least a MULIPLE of 3. A market cap of 30m would be a very conservative estimate of what Mediwatch should be on, and probably 50m is what Mediwatch deserves at this stage. Yet its valued at 6m !
That gives us a realistic price muliplication of 8 x 6m = 48m mkt cap. So 8 x 11p (share price) = 88p before it looks fully valued.
A MULIPLE OF 8 TIMES THE EXISTING SARE PRICE IS REALISTIC when compared to other firms who trade on 4/5 times next years full year revenues (if its a growth company and Mediwatch certainly is).
PLUS TWO FACTORS TO LOOK FORWARD TO :
- Mediwatch in advanced talks with a major and significant US distributor company for its product. As confirmed on the AFX statement out today. So a nice big RNS announcement is due within weeks.
- Press coverage. As yet it hasn't had much - but Investors Chronicle is out tommorrow and may cover the FDA announcement that came out from Mediwatch on Tuesday. If its not in this weeks Investors Chron (as too late to appear in thsi weeks edition) its sure to make next weeks.
Good pubilicity.
Plenty to look forward to - not least a more realistic mkt cap valuation. 6m is just way, way undervalued, and simultaneously, so is the share price.
Janus
- 28 Jan 2004 08:06
- 15 of 145
Review of the six months ended 31st October 2003
Outlook
Much has been achieved in the recent past leading to a positive perspective of
the future. FDA approval of the portable scanner and the possibility of entering
the US market, the setting up of an international distribution network and
improvements to the UK selling organisation, together with the enhancements to
the existing product range, are all significant and reassuring achievements
pointing to higher sales levels in the future. In addition, the progress made in
Mediwatch Biomedical Limited provides confidence in the long term prospects for
the Group.
Full review
http://www.uk-wire.com/cgi-bin/articles/200401280700167076U.html
Outlook
Much has been achieved in the recent past leading to a positive perspective of
the future. FDA approval of the portable scanner and the possibility of entering
the US market, the setting up of an international distribution network and
improvements to the UK selling organisation, together with the enhancements to
the existing product range, are all significant and reassuring achievements
pointing to higher sales levels in the future. In addition, the progress made in
Mediwatch Biomedical Limited provides confidence in the long term prospects for
the Group.
Full review
http://www.uk-wire.com/cgi-bin/articles/200401280700167076U.html
SueHelen
- 29 Jan 2004 09:27
- 16 of 145
RNS Number:7607U
Mediwatch PLC
29 January 2004
Mediwatch plc ('Mediwatch' or 'the Company')
Directors' Shareholdings
Rugby, UK. 29 January 2004 ... The Company received notification today that
Philip Stimpson, Chief Executive Officer of the Company, bought 125,000
ordinary shares in the Company at a price of 8.03 pence each on 28 January 2004.
Mr Stimpson now has a beneficial interest in 15,125,000 shares in the Company
representing 18.44 per cent of the issued share capital of that class.
The Company received notification today that Kevin Middis, Finance Director,
bought 60,000 ordinary shares in the Company at a price of 8.03 pence each on 28
January 2004.
The Company received notification today that Omer Karim, Non-Executive Medical
Research Director, bought 475,000 ordinary shares in the Company at a price of
8.03 pence each on 28 January 2004. Mr Karim now has a beneficial interest in
3,033,600 shares in the Company representing 3.70 per cent of the issued share
capital of that class.
Ends
For more information, visit the company's website www.mediwatch.com or contact:
Yvonne Alexander De Facto +44 20 7496 3316
y.alexander@defacto.com
Philip Stimpson Mediwatch +44 788 547 888
philip.stimpson@mediwatch.com
Except for the historical information presented, certain matters discussed in
this statement are forward looking statements that are subject to a number of
risks and uncertainties that could cause actual results to differ materially
from results, performance or achievements expressed or implied by such
statements. These risks and uncertainties may be associated with product
discovery and development, including statements regarding the company's clinical
development programmes, the expected timing of clinical trials and regulatory
filings. Such statements are based on management's current expectations, but
actual results may differ materially.
This information is provided by RNS
The company news service from the London Stock Exchange
END
Mediwatch PLC
29 January 2004
Mediwatch plc ('Mediwatch' or 'the Company')
Directors' Shareholdings
Rugby, UK. 29 January 2004 ... The Company received notification today that
Philip Stimpson, Chief Executive Officer of the Company, bought 125,000
ordinary shares in the Company at a price of 8.03 pence each on 28 January 2004.
Mr Stimpson now has a beneficial interest in 15,125,000 shares in the Company
representing 18.44 per cent of the issued share capital of that class.
The Company received notification today that Kevin Middis, Finance Director,
bought 60,000 ordinary shares in the Company at a price of 8.03 pence each on 28
January 2004.
The Company received notification today that Omer Karim, Non-Executive Medical
Research Director, bought 475,000 ordinary shares in the Company at a price of
8.03 pence each on 28 January 2004. Mr Karim now has a beneficial interest in
3,033,600 shares in the Company representing 3.70 per cent of the issued share
capital of that class.
Ends
For more information, visit the company's website www.mediwatch.com or contact:
Yvonne Alexander De Facto +44 20 7496 3316
y.alexander@defacto.com
Philip Stimpson Mediwatch +44 788 547 888
philip.stimpson@mediwatch.com
Except for the historical information presented, certain matters discussed in
this statement are forward looking statements that are subject to a number of
risks and uncertainties that could cause actual results to differ materially
from results, performance or achievements expressed or implied by such
statements. These risks and uncertainties may be associated with product
discovery and development, including statements regarding the company's clinical
development programmes, the expected timing of clinical trials and regulatory
filings. Such statements are based on management's current expectations, but
actual results may differ materially.
This information is provided by RNS
The company news service from the London Stock Exchange
END
SueHelen
- 29 Jan 2004 09:28
- 17 of 145
Price 9.0-9.5 pence, rising nicely, up 17.4%.
Could be worth adding more at these prices. The distribution deal should be imminent.
Could be worth adding more at these prices. The distribution deal should be imminent.
SueHelen
- 29 Jan 2004 09:29
- 18 of 145
In addition, good volume so far today. Trades over 15,000 shares are delayed by an hour. So the majority of earlier larger buys have appeared in the sell column.
SueHelen
- 29 Jan 2004 09:31
- 19 of 145
ckmtang - 06 Feb 2004 07:46 - 20 of 145
is it still worth to buy it now? any furhter new will be announce?
SueHelen
- 06 Feb 2004 10:29
- 21 of 145
A distribution deal is due sometime soon. Price seems to have found a new trading range at the moment with limited downside.
ckmtang - 06 Feb 2004 11:11 - 22 of 145
so when will be good to buy?
Janus
- 07 Feb 2004 17:29
- 23 of 145
Mediwatch mentioned in Shares Magazine this week.
Mediwatch chiefs scan for US profits
The likely prospect of a lucrative US distribution deal is good news for investors in AIM-listed Mediwatch (MDW).
Following publication of the interims, chief executive Philip Stimpson bought 125,000 shares and finance director Kevin Middis acquired 60,000 shares at 8.03p.
The company produces a bladder scanner which has recently received marketing approval from the FDA. This diagnostic kit can be used by a trained person, who need not be a doctor, to discover whether a patient needs specialist secondary care. It will be used in primary healthcare to screen for prostate illnesses.
Currently, the group has distribution agreements with CR Bard, one of the worlds largest suppliers of urological equipment, for distribution in parts of Europe. It is hoping to extend these arrangements to include Canada, Germany, Italy and Spain. It has signed similar distribution arrangements with a GE subsidiary to cover Japan and South-East Asia and is in the final stages of discussions about a distribution arrangement in the US an announcement is, we believe, imminent. Although currently most of the groups sales are in the UK, the company believes that in 2004/05, most will be generated overseas.
Last year, the company had to place 10 million shares at 2.5p and then seven million at 3.4p. Now that it has received FDA approval, the markets enthusiasm should continue to grow, especially when it is able to name its US partner. In the medium term, it is possible that its technology will attract a predator.
Mediwatch chiefs scan for US profits
The likely prospect of a lucrative US distribution deal is good news for investors in AIM-listed Mediwatch (MDW).
Following publication of the interims, chief executive Philip Stimpson bought 125,000 shares and finance director Kevin Middis acquired 60,000 shares at 8.03p.
The company produces a bladder scanner which has recently received marketing approval from the FDA. This diagnostic kit can be used by a trained person, who need not be a doctor, to discover whether a patient needs specialist secondary care. It will be used in primary healthcare to screen for prostate illnesses.
Currently, the group has distribution agreements with CR Bard, one of the worlds largest suppliers of urological equipment, for distribution in parts of Europe. It is hoping to extend these arrangements to include Canada, Germany, Italy and Spain. It has signed similar distribution arrangements with a GE subsidiary to cover Japan and South-East Asia and is in the final stages of discussions about a distribution arrangement in the US an announcement is, we believe, imminent. Although currently most of the groups sales are in the UK, the company believes that in 2004/05, most will be generated overseas.
Last year, the company had to place 10 million shares at 2.5p and then seven million at 3.4p. Now that it has received FDA approval, the markets enthusiasm should continue to grow, especially when it is able to name its US partner. In the medium term, it is possible that its technology will attract a predator.
goldfinger
- 11 Feb 2004 00:40
- 24 of 145
added at the very end of the day, thats around 35% up in 2 days. Far more to come me thinks.
cheers GF.
cheers GF.
Janus
- 11 Feb 2004 08:00
- 25 of 145
This was taken from another board, if true then very interesting.
Institute report - This company (MDW) is involved with a study that will inform future policy on screening for prostate cancer into a national programme. The study will take many years BUT results as they appear will be acted on earlier than the completed study. The bladder is the most likely area to develop cancer caused by radiation from X-rays ( The Lancet 2004) and ways to aviod this by new types of machinary is crucial. Any new ways to manage men with screen - detection of this disease will be supported by large sums of money.
Institute report - This company (MDW) is involved with a study that will inform future policy on screening for prostate cancer into a national programme. The study will take many years BUT results as they appear will be acted on earlier than the completed study. The bladder is the most likely area to develop cancer caused by radiation from X-rays ( The Lancet 2004) and ways to aviod this by new types of machinary is crucial. Any new ways to manage men with screen - detection of this disease will be supported by large sums of money.
kantona - 11 Feb 2004 10:57 - 26 of 145
up by 7% today ..how far can this go ..holding tight
goldfinger
- 11 Feb 2004 11:49
- 27 of 145
Dont think we have seen anything until the distribution deal is announced.
cheers GF.
cheers GF.
goldfinger
- 11 Feb 2004 21:06
- 28 of 145
Up again guys thats over 40% in three days. Still more to come though a lot more.
cheers GF.
cheers GF.
goldfinger
- 11 Feb 2004 23:27
- 29 of 145
Fingers crossed hope to be hearing about this distribution deal soon.
cheers GF.
cheers GF.
overgrowth
- 11 Feb 2004 23:54
- 30 of 145
OK - I'm in as of tomorrow for a few.
An interesting post from elsewhere a couple of days ago helps to put the fundamentals into perspective, during this frantic climb:
"Estimated annual turnover in US alone of $20m. Plus signing new distrubution deals for new products to other countries - news that will be coming in the same RNS. So add 50% for other turnover worldwide and thats $30m turnover. Say thats approx 17m (sterling) turnover potential for 04/05. Mkt cap of growth companies typically three times sales (its a far better guide than PE ratios for this sort of high growth stock). So that three times sales = fair value mkt cap of 3 x 17m = 51m mkt cap is fair value. Its now at a tiddly mkt cap of 10m ish !!! Multiple from here of 5 times the share price = genuine fair value mkt cap.
Plus : The bladder scanner is getting distrubuted worldwide in the same RNS so my annual turnover estimate of $30m only adds in $10m from outside the US, which is very conservative."
An interesting post from elsewhere a couple of days ago helps to put the fundamentals into perspective, during this frantic climb:
"Estimated annual turnover in US alone of $20m. Plus signing new distrubution deals for new products to other countries - news that will be coming in the same RNS. So add 50% for other turnover worldwide and thats $30m turnover. Say thats approx 17m (sterling) turnover potential for 04/05. Mkt cap of growth companies typically three times sales (its a far better guide than PE ratios for this sort of high growth stock). So that three times sales = fair value mkt cap of 3 x 17m = 51m mkt cap is fair value. Its now at a tiddly mkt cap of 10m ish !!! Multiple from here of 5 times the share price = genuine fair value mkt cap.
Plus : The bladder scanner is getting distrubuted worldwide in the same RNS so my annual turnover estimate of $30m only adds in $10m from outside the US, which is very conservative."
jfletendre
- 12 Feb 2004 00:59
- 31 of 145
Overgrowth - I read that post too and posted it on GF's thread - do you know enough about MDW and enough about calculating the sums in this to know if the above is accurate or just one person's very optimistic view?
goldfinger
- 12 Feb 2004 10:18
- 32 of 145
Very strong looking TA.
Positive Candidate (Medium term) - Feb 11, 2004
Has risen 555% since the bottom on 5 Jan 2004 at 2.25. An approximate horizontal trend is broken up. A continued strong development is indicated, and the stock now meets support on possible reactions down towards the trend lines. RSI is overbought. The stock can still rise further, and we should see a decreasing RSI before this is used as a negative signal. Positive volume balance, i.e. high volume in days of rising prices and low volume in days of falling prices, strengthens the stock in the short term. The stock has support at p 3.50. High risk with an average difference between the lowest and the highest price of the month of 46%.
cheers Gf.
Positive Candidate (Medium term) - Feb 11, 2004
Has risen 555% since the bottom on 5 Jan 2004 at 2.25. An approximate horizontal trend is broken up. A continued strong development is indicated, and the stock now meets support on possible reactions down towards the trend lines. RSI is overbought. The stock can still rise further, and we should see a decreasing RSI before this is used as a negative signal. Positive volume balance, i.e. high volume in days of rising prices and low volume in days of falling prices, strengthens the stock in the short term. The stock has support at p 3.50. High risk with an average difference between the lowest and the highest price of the month of 46%.
cheers Gf.
ckmtang - 12 Feb 2004 10:28 - 33 of 145
it seemed more seller rather than buyer now. can you confirmed.
goldfinger
- 12 Feb 2004 23:45
- 34 of 145
No problems I added again on the weakness this afternoon, and see these making me a very decent return.
cheers Gf.
cheers Gf.
overgrowth
- 13 Feb 2004 00:06
- 35 of 145
I agree with GF, I formerly had a stake in PRO, however they are still waiting for FDA approval with their product and there are mixed messages about distributor arrangements and competition and a host of other worries.
In contrast, MDW have the approval and distribution deals have been set up all over the globe - only the US to go and the news will be imminent.
I'm still mulling over the fundamentals in the view I posted earlier, though couldn't resist today's dip as the perfect opportunity to buy in at a decent price.
It's suspected that the MMs dropped the price a bit too low today and attracted more buyers than they expected in their tree shake - so a high mark up is predicted tomorrow. Not that I'm particularly fussed about the short term antics of this one - I've bought in for serious profits and am prepared to wait for them.
OG
In contrast, MDW have the approval and distribution deals have been set up all over the globe - only the US to go and the news will be imminent.
I'm still mulling over the fundamentals in the view I posted earlier, though couldn't resist today's dip as the perfect opportunity to buy in at a decent price.
It's suspected that the MMs dropped the price a bit too low today and attracted more buyers than they expected in their tree shake - so a high mark up is predicted tomorrow. Not that I'm particularly fussed about the short term antics of this one - I've bought in for serious profits and am prepared to wait for them.
OG
goldfinger
- 13 Feb 2004 08:47
- 36 of 145
Agree with you overgrowth and have just topped up again, not many but money from some divis. See this as a great 2004 growth story.
cheers GF.
cheers GF.
goldfinger
- 13 Feb 2004 09:29
- 37 of 145
Talk on another site that the distribution deal maybe out monday or tuesday.
Im hoping so.
cheers GF.
Im hoping so.
cheers GF.
goldfinger
- 13 Feb 2004 10:11
- 38 of 145
Freed some funds up and added even more.
cheers Gf.
cheers Gf.
overgrowth
- 13 Feb 2004 19:30
- 39 of 145
Sounds like an interesting week coming up!
goldfinger
- 16 Feb 2004 00:07
- 40 of 145
Interesting e-mail lifted from another board..........
"Thank you for recent email.
I am sure you will appreciate we are unable to be specific as to when the anticipated agreement for the distribution of the Company's bladder scanner will be concluded. You are aware of what was stated in the announcement of the Interim Results and, unfortunately, we cannot be more forthcoming at this stage. Suffice to say, the discussions are ongoing and we hope to be able to announce something in the near future."
cheers GF.
"Thank you for recent email.
I am sure you will appreciate we are unable to be specific as to when the anticipated agreement for the distribution of the Company's bladder scanner will be concluded. You are aware of what was stated in the announcement of the Interim Results and, unfortunately, we cannot be more forthcoming at this stage. Suffice to say, the discussions are ongoing and we hope to be able to announce something in the near future."
cheers GF.
goldfinger
- 16 Feb 2004 00:08
- 41 of 145
For those that didn't see it - SHARES magazine, from one week ago covered the full story, director buying and FDA approval and talked about the crucial US distribution deal - adding that "We believe an announcement is imminent" - those were the exact words used.
cheers gf.
cheers gf.
goldfinger
- 16 Feb 2004 10:49
- 42 of 145
Going up nicely again.
gf.
gf.
overgrowth
- 16 Feb 2004 20:31
- 43 of 145
The MDW chart goes from strength to strength.....
goldfinger
- 16 Feb 2004 23:27
- 44 of 145
Keep the charts coming OG. great stuff.
chears GF.
chears GF.
scotinvestor - 16 Feb 2004 23:40 - 45 of 145
just wish that announcement would come.
Can u tell me anyone who you all trade with. I tried to buy 5000 of mediwatch 2 weeks ago with halifax but could only get 3000 worth. its still ok but now a bit p???ed off as its went up quite a bit already.
I'm thinking of changing who i deal with? Any suggestions? Thanks
BTW GF, thanks for helping me with BPRG. I noticed your comments last week and bought last Tuesday. I know i'm a bit late with BPRG but wont be in 2 to 3 years time as these r a gem.
I don't always agree with your tips but then again who is an expert these days in this topsy turvy stock market.
Can u tell me anyone who you all trade with. I tried to buy 5000 of mediwatch 2 weeks ago with halifax but could only get 3000 worth. its still ok but now a bit p???ed off as its went up quite a bit already.
I'm thinking of changing who i deal with? Any suggestions? Thanks
BTW GF, thanks for helping me with BPRG. I noticed your comments last week and bought last Tuesday. I know i'm a bit late with BPRG but wont be in 2 to 3 years time as these r a gem.
I don't always agree with your tips but then again who is an expert these days in this topsy turvy stock market.
overgrowth
- 17 Feb 2004 00:45
- 46 of 145
I use a TD Waterhouse nominee account - never had any problems.
bishopjeremy
- 17 Feb 2004 12:01
- 47 of 145
bought and sold mdw through comdirect with no probs.
iamole - 17 Feb 2004 15:25 - 48 of 145
If an announcement doesn't come soon then I think the price will dip back to 10p, and I will top up. However it may announce very soon in which case 20p target I think is achievable this yr but short term it's probably been factored in, see trends before last yr as this is not a new scenario, it's just the strenghth of the sector that's changed and the US approval being added to the existing product.
goldfinger
- 17 Feb 2004 23:53
- 49 of 145
Down a tad today. Im keeping faith with this one. Its usually the case that the big boys in the US mess the little ones around for a while before agreeing on a contract. May even add as this certainly is not a one trick pony. Just been looking again at the news to come and it appears newsflow will keep this one going all the year through.
cheers GF.
cheers GF.
overgrowth
- 18 Feb 2004 00:03
- 50 of 145
GF,
I agree, this one looks better the more research you do, and talking of research and the imminent prospects of MDW's hard labours bearing many baskets of fruit, I noticed an audio interview by the Wall Street Reporter made on 21st Jan this year with the CEO.
Here's the link for anyone who hasn't heard it yet:
http://www.wallstreetreporter.com/profiles/Mediwatch.html
I agree, this one looks better the more research you do, and talking of research and the imminent prospects of MDW's hard labours bearing many baskets of fruit, I noticed an audio interview by the Wall Street Reporter made on 21st Jan this year with the CEO.
Here's the link for anyone who hasn't heard it yet:
http://www.wallstreetreporter.com/profiles/Mediwatch.html
goldfinger
- 18 Feb 2004 10:26
- 51 of 145
Well done overgrowth thats a fine piece of research. Added again this morning and now forming a nice position within this company. Dont think many have realised just how big this one could be.
cheers GF.
cheers GF.
Janus
- 18 Feb 2004 12:51
- 52 of 145
Many thanks overview. I hadnt heard this one before
overgrowth
- 18 Feb 2004 21:33
- 53 of 145
I'd top up with a few more of these also, if I had spare funds.
Plenty to look forward to:
Sales & Marketing
-----------------
US distribution contract
Canadian approval
Canadian distribution contract
Whole of Asia (including India, China, Korea, Japan) contract
Whole of Asia distribution contract
New Markets for Product Development (in next 12-18 months)
----------------------------------------------------------
GI
Cardio
Veterinary
Opthalmic
I like the sound of the fingerprint diagnostic test being the "gold mine".
These guys sounds very confident and so they should be. Now the hard start-up work has been done this one should run and run. Short term or long term, it looks as though there are going to be some very rich investors who got in at these levels.
OG
Plenty to look forward to:
Sales & Marketing
-----------------
US distribution contract
Canadian approval
Canadian distribution contract
Whole of Asia (including India, China, Korea, Japan) contract
Whole of Asia distribution contract
New Markets for Product Development (in next 12-18 months)
----------------------------------------------------------
GI
Cardio
Veterinary
Opthalmic
I like the sound of the fingerprint diagnostic test being the "gold mine".
These guys sounds very confident and so they should be. Now the hard start-up work has been done this one should run and run. Short term or long term, it looks as though there are going to be some very rich investors who got in at these levels.
OG
goldfinger
- 22 Feb 2004 20:52
- 54 of 145
Will we get the distribution deal this week, any one with any info???????
cheers GF.
cheers GF.
Oakapples
- 23 Feb 2004 09:45
- 55 of 145
Me too - this is currently my big loser
kantona - 23 Feb 2004 15:05 - 56 of 145
the share price now is coming back up .. i personally think there was bound to be some profit taking after such a strong run ..this vll come good ..just a case of being patient and strong
kantona - 23 Feb 2004 15:05 - 57 of 145
goldfinger
- 23 Feb 2004 16:26
- 58 of 145
Yes patience, probably the most valuable tool when investing.
cheers GF.
cheers GF.
overgrowth
- 23 Feb 2004 21:05
- 59 of 145
GF - I agree, have just been reading "Reminiscences of a Stock Operator" and that really rams home the point that the really big gains are made by spotting a big opportunity, trading at the point you think best and then waiting and waiting until it all comes together.
MDW is such a gem at these prices because we already know that there is a consistent stream of newsflow to come, the US distribution deal being just a start and for small companies good newsflow is crucial to keeping the press and punters interested.
All will be revealed in good time.
OG
MDW is such a gem at these prices because we already know that there is a consistent stream of newsflow to come, the US distribution deal being just a start and for small companies good newsflow is crucial to keeping the press and punters interested.
All will be revealed in good time.
OG
goldfinger
- 23 Feb 2004 21:15
- 60 of 145
Couldnt agree more overgrowth. Too many people panic on short term movements.
cheers GF.
cheers GF.
scotinvestor - 23 Feb 2004 21:19 - 61 of 145
i bought in at just under 10p so no panic for me as yet. However, looking at chart, i think we are due another big hike up very soon. Any experienced chartists out there to back up my claims
goldfinger
- 25 Feb 2004 00:01
- 62 of 145
Not a chartist scotinvestor just hoping the do manage to rally.
cheers GF.
cheers GF.
overgrowth
- 25 Feb 2004 00:45
- 63 of 145
The one month candlestick chart shows the recent trend turning bullish again:
The dragonfly doji (horizontal line with vertical underneath) is a respected bullish sign after a downtrend. This means that support brought the price back up to where it started from.
The hammer (rectangle with long vertical underneath) is also well-known as a bullish signal, heralding the "hammering up" of the price imminently - note that this powering up of bullishness does not always happen in the next session, but is sure to follow soon. This hammer also emphasises very strong support at 11.5p.
So, it looks like the chart is saying that the deal could be announced before the end of the week. If this is not the case, then it looks as though there will be renwed bullish interest in the prospects of the company in general (or in anticipation of the deal or a host of other reasons which TA's don't care about anyway when looking at the charts).
The dragonfly doji (horizontal line with vertical underneath) is a respected bullish sign after a downtrend. This means that support brought the price back up to where it started from.
The hammer (rectangle with long vertical underneath) is also well-known as a bullish signal, heralding the "hammering up" of the price imminently - note that this powering up of bullishness does not always happen in the next session, but is sure to follow soon. This hammer also emphasises very strong support at 11.5p.
So, it looks like the chart is saying that the deal could be announced before the end of the week. If this is not the case, then it looks as though there will be renwed bullish interest in the prospects of the company in general (or in anticipation of the deal or a host of other reasons which TA's don't care about anyway when looking at the charts).
kantona - 25 Feb 2004 22:48 - 64 of 145
like i said before if this one goes down further take it as an opprtunity to top up ..least thats what i feel ..
just to refresh our memory here is the last RNS re the FDA approval ..the important info is in the last paragraph and i quote from there..
"We are in advanced stages to conclude a distribution agreement with a large, well-established international company that is already selling into closely related markets" ..so i for one not yet concerned about the currrent downward pressure on price ..just a matter of time b4 details r released .. i'm holding as long as it takes.
Mediwatch PLC
20 January 2004
Mediwatch Secures FDA Marketing Approval for Portascan(R)
Rugby, UK - 20 January, 2004 - Mediwatch, the innovative UK manufacturer of high
tech screening and diagnostic systems for urological disorders, announced today
that it has received marketing approval from the US Food and Drug Administration
(FDA) for the Portascan(R) portable bladder scanner in the USA.
The state-of-the-art portable diagnostic will be used to screen patients
suffering from prostate and bladder disorders, incontinence and those requiring
catheterization. Doctors' offices, outpatient clinics, hospital emergency
departments and nursing homes are all potential users of the Portascan, where
its level of accuracy gives it a major advantage over its competitors This
approval provides Mediwatch with access to the lucrative US bladder screening
market, currently valued at between $15 and $20 million per annum.
Commenting on this development, Philip Stimpson, CEO, said, 'Breaking into the
US market represents a significant milestone for Mediwatch. We are in advanced
stages to conclude a distribution agreement with a large, well-established
international company that is already selling into closely related markets.
Although this is our first venture into the US, we have already signed similar
agreements with multi-nationals to distribute our products across Europe.'
just to refresh our memory here is the last RNS re the FDA approval ..the important info is in the last paragraph and i quote from there..
"We are in advanced stages to conclude a distribution agreement with a large, well-established international company that is already selling into closely related markets" ..so i for one not yet concerned about the currrent downward pressure on price ..just a matter of time b4 details r released .. i'm holding as long as it takes.
Mediwatch PLC
20 January 2004
Mediwatch Secures FDA Marketing Approval for Portascan(R)
Rugby, UK - 20 January, 2004 - Mediwatch, the innovative UK manufacturer of high
tech screening and diagnostic systems for urological disorders, announced today
that it has received marketing approval from the US Food and Drug Administration
(FDA) for the Portascan(R) portable bladder scanner in the USA.
The state-of-the-art portable diagnostic will be used to screen patients
suffering from prostate and bladder disorders, incontinence and those requiring
catheterization. Doctors' offices, outpatient clinics, hospital emergency
departments and nursing homes are all potential users of the Portascan, where
its level of accuracy gives it a major advantage over its competitors This
approval provides Mediwatch with access to the lucrative US bladder screening
market, currently valued at between $15 and $20 million per annum.
Commenting on this development, Philip Stimpson, CEO, said, 'Breaking into the
US market represents a significant milestone for Mediwatch. We are in advanced
stages to conclude a distribution agreement with a large, well-established
international company that is already selling into closely related markets.
Although this is our first venture into the US, we have already signed similar
agreements with multi-nationals to distribute our products across Europe.'
scotinvestor - 26 Feb 2004 13:09 - 65 of 145
many people must be losing a lot on this one already. i noticed people on this buying at 13-14 p levels. you have to sell at 11p already.
i'm still going to sit this one out just like i did with RTD. if u believe in something, then stick by it. the day traders stuff up small cap shares like this one but long term they cant do anything.
i'm still going to sit this one out just like i did with RTD. if u believe in something, then stick by it. the day traders stuff up small cap shares like this one but long term they cant do anything.
grajul - 26 Feb 2004 13:43 - 66 of 145
could not agree more scotinvestor. This is a good company and will recover I am sure. I will be sitting this one out.
overgrowth
- 27 Feb 2004 01:21
- 67 of 145
I agree folks,
The brokers say that the MM's are collecting as much stock as they can because they know that they're going to sell it by the bucketful when the distribution deal is announced. This is a golden opportunity to buy in before the next massive surge.
I hope it keeps at this level for the next couple of trading days so I have the cash to top-up, although judging by the current market trends, it wouldn't surprise me at all if an RNS pops up tomorrow or Monday and scuppers my plans.
OG
The brokers say that the MM's are collecting as much stock as they can because they know that they're going to sell it by the bucketful when the distribution deal is announced. This is a golden opportunity to buy in before the next massive surge.
I hope it keeps at this level for the next couple of trading days so I have the cash to top-up, although judging by the current market trends, it wouldn't surprise me at all if an RNS pops up tomorrow or Monday and scuppers my plans.
OG
overgrowth
- 27 Feb 2004 22:13
- 68 of 145
Typical - the price is starting to rise again (albeit very slightly), I'd say it looks like an evens bet on news early next week.
goldfinger
- 28 Feb 2004 23:35
- 69 of 145
Yup nice to see them start to rise again.
cheers GF.
cheers GF.
goldfinger
- 01 Mar 2004 00:12
- 70 of 145
Another day up Guys?????
cheers GF.
cheers GF.
goldfinger
- 01 Mar 2004 08:45
- 71 of 145
Yup were up this morning. Lets hope we can maintain it.
cheers gf.
cheers gf.
hondaman - 03 Mar 2004 12:27 - 72 of 145
announcement imminent - was delayed because of management change at USA partner as per reply from MDW Director.
scotinvestor - 03 Mar 2004 12:52 - 73 of 145
thanks for that hondaman
Janus
- 03 Mar 2004 14:01
- 74 of 145
Cardinal Health maybe ?
Cardinal Health Inc. has promoted George Fotiades to the newly created position of president and chief operating officer.
Fotiades was president and chief executive officer of Cardinal Health's Life Sciences business since 2000, and now all of the company's operations will report to him.
Company founder Robert Walter retains the titles of chairman and CEO.
"With George at the operational helm, my focus will be on corporate strategy, capital deployment and leadership development," Walter said in a press release.
Cardinal hasn't had a president since John Kane retired in 2000. The company eliminated the title following his retirement.
Dublin-based Cardinal is a global provider of goods and services to the health care industry.
James Millar, president and CEO of Cardinal's Healthcare Products and Services unit, has been transferred to the new position of executive director for strategic initiatives. He will advise Fotiades and report to Walter.
Also, Ronald Labrum was appointed president and CEO of the newly created Integrated Provider Solutions organization, which will hold Cardinal's medical products and services, clinical consulting and services and specialty distribution.
http://columbus.bizjournals.com/columbus/stories/2004/02/02/daily13.html
Cardinal Health Inc. has promoted George Fotiades to the newly created position of president and chief operating officer.
Fotiades was president and chief executive officer of Cardinal Health's Life Sciences business since 2000, and now all of the company's operations will report to him.
Company founder Robert Walter retains the titles of chairman and CEO.
"With George at the operational helm, my focus will be on corporate strategy, capital deployment and leadership development," Walter said in a press release.
Cardinal hasn't had a president since John Kane retired in 2000. The company eliminated the title following his retirement.
Dublin-based Cardinal is a global provider of goods and services to the health care industry.
James Millar, president and CEO of Cardinal's Healthcare Products and Services unit, has been transferred to the new position of executive director for strategic initiatives. He will advise Fotiades and report to Walter.
Also, Ronald Labrum was appointed president and CEO of the newly created Integrated Provider Solutions organization, which will hold Cardinal's medical products and services, clinical consulting and services and specialty distribution.
http://columbus.bizjournals.com/columbus/stories/2004/02/02/daily13.html
kantona - 08 Mar 2004 20:24 - 75 of 145
these have been nudging up nicely for the last few days .. thought bring thread back as i feel it won't b long before the details of the contract is released.
overgrowth
- 08 Mar 2004 22:49
- 76 of 145
Kantona,
I agree, looks as though we're getting very close now. 20p could be on the cards very soon.
OG
I agree, looks as though we're getting very close now. 20p could be on the cards very soon.
OG
banjomick
- 09 Mar 2004 01:42
- 77 of 145
fingers crossed,20p sounds vg
goldfinger
- 10 Mar 2004 00:47
- 78 of 145
Right lets hope we get the news on a good day on the market.
cheers GF.
cheers GF.
scotinvestor - 10 Mar 2004 21:51 - 79 of 145
i dont think we will get news until end of March or thereabouts. However, i am happy to wait. Price will stay around current prices in last few weeks.
PS: In case no-one noticed my prev posts, i know of a very close source up here in Aberdeen and BG Group are in final throws of being taken over by Total. Both are big exploration companies worldwide offshore. Chairman of BG bought 28,000 shares at around 80000 recently and results were excellent. City dont know about this REAL bit of awesome news. A giveaway to me this one.
PS: In case no-one noticed my prev posts, i know of a very close source up here in Aberdeen and BG Group are in final throws of being taken over by Total. Both are big exploration companies worldwide offshore. Chairman of BG bought 28,000 shares at around 80000 recently and results were excellent. City dont know about this REAL bit of awesome news. A giveaway to me this one.
kantona - 12 Mar 2004 12:00 - 80 of 145
the chart is showing good upward trend now after the lows of yesterday .. has good support at the current levels ..
robstuff - 16 Mar 2004 17:02 - 81 of 145
Can't see it. Getting nervous! where's that deal?
goldfinger
- 17 Mar 2004 20:53
- 82 of 145
Anyone with any news??????.
cheers GF.
cheers GF.
overgrowth
- 18 Mar 2004 00:32
- 83 of 145
I doubt if the deal will be announced before the end of March, though sometime in April will have allowed plenty of time for the US distribution co. to get down to business after their board changes.
MDW is a snip at these prices and the price is starting to rise again. Don't hang about if any of you folks are thinking of snapping a few more up at the right price.
The company appears to be gradually getting more and more of a following amongst investors. A large rise when the deal is announced will help put them on a lot more radars so should bode well for the short term.
Long term - don't forget all that news we've still to look forward to :))
Cheers
OG
MDW is a snip at these prices and the price is starting to rise again. Don't hang about if any of you folks are thinking of snapping a few more up at the right price.
The company appears to be gradually getting more and more of a following amongst investors. A large rise when the deal is announced will help put them on a lot more radars so should bode well for the short term.
Long term - don't forget all that news we've still to look forward to :))
Cheers
OG
kantona - 26 Mar 2004 10:51 - 84 of 145
something brewing .. mm have raised the bids from 9.75 to 11.5 in space of 5 mins currently 11.5 - 13
kantona - 26 Mar 2004 10:56 - 85 of 145
going through the roof ....
goldfinger
- 26 Mar 2004 11:06
- 86 of 145
Whats going on???????????, anyway added for more, think we might get a follow on from small caps in the US this afternoon.
cheers GF.
cheers GF.
robstuff - 26 Mar 2004 12:12 - 87 of 145
Now it's going down as fast as it went up, will prob end the day down but lets hope not.
goldfinger
- 26 Mar 2004 12:59
- 88 of 145
I expect the news to come from the other side of the pond before it is released here. Dont care wether its this afternoon next week or next month, theres plenty of newsflow forecast for this one throughout the year.
cheers Gf.
cheers Gf.
overgrowth
- 26 Mar 2004 23:31
- 89 of 145
Typical - just as I was waiting patiently to up my stake to a substantial amount at the bargain price from yesterday, thwarted at the last minute without any news. Just imagine what is going to happen when the good news continues to be announced. Not many shares in circulation, so we are likely to see some phenomenal rises in price this year.
Still up 18% at the close and this is just the start.
These guys have been slogging away for the past 5 years and all the hard work is now coming to fruition and will continue.
Hard to predict where the price will be in a year, though it looks like a potential "5-bagger" to me.
OG
Still up 18% at the close and this is just the start.
These guys have been slogging away for the past 5 years and all the hard work is now coming to fruition and will continue.
Hard to predict where the price will be in a year, though it looks like a potential "5-bagger" to me.
OG
SueHelen
- 29 Mar 2004 13:48
- 90 of 145
Added into these again. The US distribution deal should be coming very soon now.
robstuff - 29 Mar 2004 14:36 - 91 of 145
was looking to buy more myself yesterday morning at 10.25p, hesitated and missed the opp, but got in on DES Friday, this could be a 30bagger, take a look, they're sitting on a monster!
SueHelen
- 29 Mar 2004 17:32
- 92 of 145
Strong close today at 12.0-12.25 pence, very tight spread. We should see a strong rise tomorrow and rest of the week.
SueHelen
- 29 Mar 2004 17:33
- 93 of 145
3 good delayed buys have been reported after close, appeared in the sell column (2 of them).
SueHelen
- 29 Mar 2004 17:36
- 94 of 145
SueHelen
- 29 Mar 2004 17:38
- 95 of 145
The price has crossed the ten and fifty day moving averages which is a boost.
overgrowth
- 29 Mar 2004 23:40
- 96 of 145
MDW should be testing 15p soon - it'll be an interesting week, particularly if the much awaited news of the deal is forthcoming.
Philip Stimpson was out of the office a lot of last week. Was he over in the US ? Signing on the dotted line ?
Philip Stimpson was out of the office a lot of last week. Was he over in the US ? Signing on the dotted line ?
SueHelen
- 30 Mar 2004 14:21
- 97 of 145
Price consolidating after the intial rise this morning. 50K buy just been reported at full price of 12.5 pence.
robstuff - 31 Mar 2004 16:50 - 98 of 145
Should it be taking this long? It was supposed to be imminent in jan, can it be such a marvellous product if no-one will sell it? Come on guys, do the deal or the share price next stop is 8p
kantona - 02 Apr 2004 15:19 - 99 of 145
the price has been ticking up today .. some big trades going through one mm buy at 250,000 ..couple at 100,000
overgrowth
- 14 Apr 2004 21:47
- 100 of 145
Things have been quiet at Mediwatch recently, however there's an interesting post from Booza on iii:
"Ive just had a nice chat with Mr Alun Hicks (Non-Executive Director) at Mediwatch about one of my emails to Mr Philip Stimpson in which I questioned his sincerity about the imminence of the US distribution announcement. Mr Stimpson is currently in Egypt on business so Mr Hicks contacted me on his behalf.
Mr Hicks explained that at the time of the statement on the 20th Jan, everything Mr Stimpson said was true and in good faith. He also said that the delay is due to the size and complexity of deal which is still very dynamic. He assured me that they are working flat out to conclude the situation and will announce something as soon as possible.
One very interesting point came out when I accidentally described the deal as massive Mr Hicks hastily replied Well, Id hardly describe 15 to 20 million as massive but to a small AIM listed company it is certainly huge..
"
It certainly looks as though there are going to be exciting times ahead!
"Ive just had a nice chat with Mr Alun Hicks (Non-Executive Director) at Mediwatch about one of my emails to Mr Philip Stimpson in which I questioned his sincerity about the imminence of the US distribution announcement. Mr Stimpson is currently in Egypt on business so Mr Hicks contacted me on his behalf.
Mr Hicks explained that at the time of the statement on the 20th Jan, everything Mr Stimpson said was true and in good faith. He also said that the delay is due to the size and complexity of deal which is still very dynamic. He assured me that they are working flat out to conclude the situation and will announce something as soon as possible.
One very interesting point came out when I accidentally described the deal as massive Mr Hicks hastily replied Well, Id hardly describe 15 to 20 million as massive but to a small AIM listed company it is certainly huge..
"
It certainly looks as though there are going to be exciting times ahead!
overgrowth
- 20 Apr 2004 23:22
- 101 of 145
Some very interesting spread movements today. It looks as though news of some form is really "imminent" now. If we see another strong rise tomorrow with no news, then an RNS will be on its way before the week's out.
grajul - 30 Apr 2004 13:16 - 102 of 145
I've topped up today, these are amazingly cheap now, just falling away due to no news. Once the news comes through though, this'll rock. (I'm an optomist, you know)
overgrowth
- 03 May 2004 23:06
- 103 of 145
grajul - I agree. There are rumours floating around that there will be news of one form or another in the first week of May, if that's the case we won't have long to wait!
cathbroadley - 14 May 2004 21:20 - 104 of 145
Goldfinger are you still holding mdw,what is your view on them now thanks Cath.
goldfinger
- 15 May 2004 23:57
- 105 of 145
Hi Cath got your message, still holding but highly dissapointed with the share price ( mind in these markets cant ask for more).
Remember its not a one trick pony this one and being a highly patient type Im prepared to sit back and wait for news which will out it and move the price higher.
More or less same thing going on at BPRG but shorters seem to be having there day there, but for how much longer? and I for one hope they get caught in a bear trap, and if they do they will wish they never heard of the shorting practice, it could happen and they could get locked in.
Only about 10 stock now open, mt exposure to tech is now very limited mind I cant complain Ive had an excelent 12 months or so, now going back to cash and the odd defensive and value share.
Hope you are doing ok on the markets, its a pity but these geopolitical problems cant be forecast.
Good luck and regards goldfinger.
Remember its not a one trick pony this one and being a highly patient type Im prepared to sit back and wait for news which will out it and move the price higher.
More or less same thing going on at BPRG but shorters seem to be having there day there, but for how much longer? and I for one hope they get caught in a bear trap, and if they do they will wish they never heard of the shorting practice, it could happen and they could get locked in.
Only about 10 stock now open, mt exposure to tech is now very limited mind I cant complain Ive had an excelent 12 months or so, now going back to cash and the odd defensive and value share.
Hope you are doing ok on the markets, its a pity but these geopolitical problems cant be forecast.
Good luck and regards goldfinger.
cathbroadley - 16 May 2004 10:44 - 106 of 145
Thanks GF will stick with it not in a hurry can wait a year if need be down about 30% in all my holdings will have to be patient Cath.
overgrowth
- 16 May 2004 20:29
- 107 of 145
Well worth sticking with this co. There's still a stack of newsflow to come and each announcement will be nudging the price nicely upwards.
The drift is disappointing, though it has mainly been on relatively tiny volumes which means that the price can easily blast back up to 12-15p levels on positive news.
The drift is disappointing, though it has mainly been on relatively tiny volumes which means that the price can easily blast back up to 12-15p levels on positive news.
overgrowth
- 27 May 2004 20:03
- 108 of 145
Great news in the trading update today - the RNS has emphatically quashed any bearish thoughts on MDW:
"Mediwatch (AIM:MDW), the innovative UK manufacturer of high tech screening and
diagnostic systems for urological disorders, today announces a business update.
The Company announces that Phase I clinical evaluation of the qualitative
point-of-care diagnostic system (PSA) has commenced. Mediwatch Biomedical
remains on course to apply for regulatory approvals for this point-of-care
system in Europe and the US next year.
Progress has been made in the UK where sales have increased significantly during
the second half of the year ending 30th April 2004. In addition, CMDCAS approval
for Canada has now been granted for a portable scanner.
Professor Peter Wells, a world leading expert in Ultrasound has agreed to join
the Company as a consultant and will provide further expertise in support of new
and exciting future products.
As announced in the interim results to 31st October 2003 released on 28th
January 2004, negotiations with a large US distributor for a range of Mediwatch
products are continuing, albeit somewhat delayed due to unforeseen legal issues.
Resolution of these issues is currently being addressed and we will provide an
update to shareholders in due course."
If UK sales alone "have increased significantly" what sort of volumes are going to be sold by this company globally when they really get going.
A good price to buy, now we have confirmation from the horse's mouth that MDW is more than on the right track.
As has been mentioned some time ago, plenty of newsflow regarding new distribution deals to come and lots of exciting products in the pipeline.
"Mediwatch (AIM:MDW), the innovative UK manufacturer of high tech screening and
diagnostic systems for urological disorders, today announces a business update.
The Company announces that Phase I clinical evaluation of the qualitative
point-of-care diagnostic system (PSA) has commenced. Mediwatch Biomedical
remains on course to apply for regulatory approvals for this point-of-care
system in Europe and the US next year.
Progress has been made in the UK where sales have increased significantly during
the second half of the year ending 30th April 2004. In addition, CMDCAS approval
for Canada has now been granted for a portable scanner.
Professor Peter Wells, a world leading expert in Ultrasound has agreed to join
the Company as a consultant and will provide further expertise in support of new
and exciting future products.
As announced in the interim results to 31st October 2003 released on 28th
January 2004, negotiations with a large US distributor for a range of Mediwatch
products are continuing, albeit somewhat delayed due to unforeseen legal issues.
Resolution of these issues is currently being addressed and we will provide an
update to shareholders in due course."
If UK sales alone "have increased significantly" what sort of volumes are going to be sold by this company globally when they really get going.
A good price to buy, now we have confirmation from the horse's mouth that MDW is more than on the right track.
As has been mentioned some time ago, plenty of newsflow regarding new distribution deals to come and lots of exciting products in the pipeline.
overgrowth
- 27 May 2004 23:06
- 109 of 145
I'm surprised there's so little interest here for a company which has just risen 32.6% today.
banjomick
- 27 May 2004 23:32
- 110 of 145
me too,any reason?
overgrowth
- 27 May 2004 23:52
- 111 of 145
I reckon a lot of folks looked at the potential earlier in the year, bought in at a high (12-14p) and reluctantly sold at a loss after the widely reported "imminent" distribution deal took a few months longer than expected and the share price dwindled helped along by general market conditions.
This RNS is just the start - lots more news to come, we just need to be patient.
This RNS is just the start - lots more news to come, we just need to be patient.
overgrowth
- 09 Jun 2004 23:33
- 112 of 145
Looks like folks are just starting to buy in again. Just as I was hoping to pick up a cartload at 5p!!!!!
overgrowth
- 18 Jun 2004 08:41
- 113 of 145
There appears to be renewed action in MDW (albeit slight) recently folks - keep an eye out for news as this is will soar when news confirming the US distribution deal comes out.
stocktock - 18 Jun 2004 08:54 - 114 of 145
I am holding for the long term. I managed to purchase 30,000 this am (further increasing my holding whilst this shares are in recline) - I believe these shares are extremely cheap bearing in mind the fundamentals and the extensive medical products they have. The potential is vast bearing in mind the amount of health service organisations and individuals who would use these equipment. For those who hold and have note checked out there web site - they should. The site is very enlightning. Do notworry about the recent downfall and fluctuation in prices - sentiment is also following the market and unfortunately Mediwatch has been included in this - unjustified!Do not expect to make a quick buck - but for those who hold patience will be rewarded. As usual do your own research and find the time to speak to the Director of Mediwatch - which I did. This discussion alone gave me further confidence in their products. Regards
overgrowth
- 18 Jun 2004 18:41
- 115 of 145
stocktock - I'm in for the long term and totally agree with all points apart from "Do not expect to make a quick buck" - MDW is on a lot of watch lists waiting for the deal to be confirmed, as soon as that happens the price will be way above 10p in an instant.
Slightly longer term we could well be looking at a small company making it to the big time. 1-2 years with the right deals and products (all in the pipeline - not pie in the sky), we're likely to be looking at a price range of 50p-70p.
Slightly longer term we could well be looking at a small company making it to the big time. 1-2 years with the right deals and products (all in the pipeline - not pie in the sky), we're likely to be looking at a price range of 50p-70p.
petralva
- 20 Jun 2004 08:53
- 116 of 145
agree with all the above,but lets hope it can get above 8p or will end up back in a bull trap.
petralva
- 20 Jun 2004 08:54
- 117 of 145
leftie - 20 Jun 2004 10:02 - 118 of 145
Yes like this one , looking for 20 -30p by the end of the year. Big deals on the way I hear.
overgrowth
- 20 Jun 2004 20:28
- 119 of 145
Big deals, solid current line of products and a strong pipeline of even more lucrative products coming up soon (some branching out into other areas of business).
This is going to go very wild soon.
This is going to go very wild soon.
cathbroadley - 29 Jun 2004 09:07 - 120 of 145
Rummer on advfn there will be news realised on friday
Oakapples142
- 29 Jun 2004 09:18
- 121 of 145
Lets keep the rumours going = up 10% and rising as I type.
cathbroadley - 29 Jun 2004 15:28 - 122 of 145
Heading up again lot of buying
overgrowth
- 30 Jun 2004 00:59
- 123 of 145
There are not many shares available in MDW to snap up, so large volume buying will shift the price up very quickly indeed.
As soon as the newsflow starts, this one will run and run.
With a massive health awareness drive in the US highlighting the problem of prostate cancer, the announcement of the large US distribution deal will cause MDW to fly.
http://www.mediwatch.co.uk/mediwatch/index.html
As soon as the newsflow starts, this one will run and run.
With a massive health awareness drive in the US highlighting the problem of prostate cancer, the announcement of the large US distribution deal will cause MDW to fly.
http://www.mediwatch.co.uk/mediwatch/index.html
overgrowth
- 01 Jul 2004 01:20
- 124 of 145
A day or two of consolidation like today is very healthy for the rises to come -annoying if you've just bought in, however temporary drops will be nothing when you consider the returns to be made in the second half of this year.
For anyone buying 8.8p looks like the next "bounce point" if there is further consolidation. If we go up tomorrow instead, then get in as soon as you can, because if news really is round the corner we can expect some large hikes in price.
Something must have triggered the rumour mongers to cause the increase in volume we've seen over the past few of days - let's see what happens on Friday.
For anyone buying 8.8p looks like the next "bounce point" if there is further consolidation. If we go up tomorrow instead, then get in as soon as you can, because if news really is round the corner we can expect some large hikes in price.
Something must have triggered the rumour mongers to cause the increase in volume we've seen over the past few of days - let's see what happens on Friday.
overgrowth
- 02 Jul 2004 01:18
- 125 of 145
Only me interested in MDW by the looks of it - ah well, you've only got yourselves to blame when you're tempted to buy in at much higher prices.
I have a feeling this BB will become a little bit more active if the much rumoured announcement is made today.
No news as yet suggests that if there is any news today it will be made around 1:30pm just before Wall Street opens, because it relates to the US deal and MDW wouldn't want their US investors to miss out on a chance to invest at a low price - we'll just have to wait and see...
I have a feeling this BB will become a little bit more active if the much rumoured announcement is made today.
No news as yet suggests that if there is any news today it will be made around 1:30pm just before Wall Street opens, because it relates to the US deal and MDW wouldn't want their US investors to miss out on a chance to invest at a low price - we'll just have to wait and see...
grajul - 02 Jul 2004 12:01 - 126 of 145
I have been in on this for a while Overgrowth, on a loss just now, but I am resisting averaging down, I would be too exposed. I am happy to wait an dreap the rewards when (not if) mdw take soff. Good luck to all....
scotinvestor - 02 Jul 2004 14:49 - 127 of 145
wheres the so called news that was supposed to be appearing today
overgrowth
- 02 Jul 2004 19:24
- 128 of 145
Ah well - rumours abound with Mediwatch concerning the much awaited "announcement", however this one sounded more promising than others, though could have been misconstrued as insider information - we could find that the date has been moved into next week because of this.
Whatever happens in the next few days, I can really sense this company being a goldmine in the short, medium and long term.
grajul - I'm still on a loss too, though decided to top up with another 50% worth at the recent low prices. As they're an AIM stock, it's worth hanging on for 2 years+ to get the full CGT allowance - by that time the price should be more around the 1 mark. There's not much free stock so the price will zoom with heavy buying volumes - after then we have interest from institutions to look forward to.
Whatever happens in the next few days, I can really sense this company being a goldmine in the short, medium and long term.
grajul - I'm still on a loss too, though decided to top up with another 50% worth at the recent low prices. As they're an AIM stock, it's worth hanging on for 2 years+ to get the full CGT allowance - by that time the price should be more around the 1 mark. There's not much free stock so the price will zoom with heavy buying volumes - after then we have interest from institutions to look forward to.
Oakapples142
- 05 Jul 2004 09:26
- 129 of 145
A little antipation going on again this morning. I must say that rumours make the game rather more interestng and give us the opportunity to buy and sell making modest profit practically weekly!!.
Oakapples142
- 06 Jul 2004 09:21
- 130 of 145
You have all gone a little quiet this morning. As I predicted great chance to buy for the brave this morning - I did at 7.05 - well just a little !!
overgrowth
- 06 Jul 2004 19:54
- 131 of 145
Oakapples,
And a well timed move it was too.
1.2M loss vs 5.46M is the bottom line which is a substantial improvement on last year.
Far too many people were expecting sparkling results in addition to an annoucement over the US distribution deal and raced for the sell button (rather prematurely in my view).
The news which will really shift the price North with huge momentum is that on the distribution deal. I'm assuming that the modest placement will act as an insurance to cover cash flow during the period between shipping products and being paid by the distributor - because there could be one hell of a load of products needed in the US.
The placing will set a stable level for the price, which looks as though it will oscillate in the range 6-7p. As soon as there's any whiff of news on distribution deals, the buyers will be back in force, and the price could well be almost doubled in a single day's trading - so keep an eye on the news. The RNS said nothing really about deals, so we can expect news tomorrow just as much as in several months.
This is a high risk/high reward share. I believe that the brave will seriously prosper in the long run. At these levels MDW is still a tremendous bargain. 50p+ is still not unlikely by this time next year.
And a well timed move it was too.
1.2M loss vs 5.46M is the bottom line which is a substantial improvement on last year.
Far too many people were expecting sparkling results in addition to an annoucement over the US distribution deal and raced for the sell button (rather prematurely in my view).
The news which will really shift the price North with huge momentum is that on the distribution deal. I'm assuming that the modest placement will act as an insurance to cover cash flow during the period between shipping products and being paid by the distributor - because there could be one hell of a load of products needed in the US.
The placing will set a stable level for the price, which looks as though it will oscillate in the range 6-7p. As soon as there's any whiff of news on distribution deals, the buyers will be back in force, and the price could well be almost doubled in a single day's trading - so keep an eye on the news. The RNS said nothing really about deals, so we can expect news tomorrow just as much as in several months.
This is a high risk/high reward share. I believe that the brave will seriously prosper in the long run. At these levels MDW is still a tremendous bargain. 50p+ is still not unlikely by this time next year.
overgrowth
- 08 Jul 2004 19:48
- 132 of 145
oakapples - did you see the RNS today ?
Directors putting their hands in their pockets and stumping up loads of cash - they must know that it is going to be returned to them several times over :-)
Directors putting their hands in their pockets and stumping up loads of cash - they must know that it is going to be returned to them several times over :-)
Oakapples142
- 09 Jul 2004 09:47
- 133 of 145
overgrowth - roger - I have just had a call from a Professor friend in Harrogate who advises me to top up again - I confirm that insider training is not involved but I am in for a "double" with him and the Directors opening their wallets. Good luck
Happy1 - 20 Jul 2004 11:30 - 134 of 145
Good buying opportunity as you can get them for 6p when the recent placing which was taken up by the Directors and Institutions was at 6.25p.
Happy1 - 20 Jul 2004 13:16 - 135 of 145
Look good value at 6p after reading this;
Innovative UK manufacturer of high tech screening and diagnostic systems for urological disorders.
Latest Business Organisational Update
FDA approval of the Portascan applied for and subsequently granted in
December 2003.
Distribution agreements put in place in important markets across the
world.
UK sales organisation rebuilt and refocused.
New product opportunities to complement and strengthen the existing
range identified.
Satisfactory progress with the development of the quantitative point of
care PSA diagnostic system.
Financials
Interims31/10/2003.
The operating margin in the period was 32% compared with 31% in the previous
year and the benefits of tight control of overheads resulted in expenditure of
590,000, - 115,000 less than in the comparable prior year period. In summary
therefore, the operating loss, after 174,000 amortisation of goodwill (231,000
in 2002), was 641,000 compared with 689,000 for the six months to 31st October
2002.
Cash on the books was 418,000 compared to 64,000 at the same time last year. With Sales increasing the position of the company gets stronger by the day.
Technical Products Update
A joint venture with two US corporations to develop the next generation
of the one-stop diagnostic system. This product should be launched in the second
half of 2004.
The development of a disposable product to assist control of
incontinence associated with prostate conditions. This will be available mid
2004.
The development of a compact specimen collection device for prostate
biopsies. This will be available mid 2004.
Preliminary plans to extend the portable bladder scanner range into
three other pathology areas.
Forward Outlook
A recovery in UK sales is
underway and negotiations with C R Bard for up to 9 other European countries
plus the Middle East to become party to the scanner supply agreement are
progressing. Export markets were a major focus for business development in the
period and distribution agreements were signed covering Japan, South East Asia
including Australasia. Negotiations are also in progress for sales
representation in India, Korea, China and Japan (for products not already included)
Jewel In The Crown
Most importantly however, access to the huge US market will have the
most significant impact on future sales and during the period FDA approval was
sought and recently received for the portable bladder scanner. Negotiations are
now at final stage with a large US distributor in relation to this and other
products of the Group.
CEO Philip Stimpson commented after the FDA approval for the portable bladder scanner, "the company is close to signing a distribution deal with a major International healthcare group"
Directors Buys
29 January 2004 ... The Company received notification today that
Philip Stimpson, Chief Executive Officer of the Company, bought 125,000
ordinary shares in the Company at a price of 8.03 pence each on 28 January 2004.
Kevin Middis, Finance Director,
bought 60,000 ordinary shares in the Company at a price of 8.03 pence each on 28
January 2004.
Omer Karim, Non-Executive Medical
Research Director, bought 475,000 ordinary shares in the Company at a price of
8.03 pence each on 28 January 2004.
A CLEAR SIGN THAT THE MANAGEMENT ARE VERY CONFIDENT OF THE COMPANYS FUTURE
Company Website
www.mediwatch.com
Summing up the shares are around 10.2p to buy and there are circa of 23.4 million in circulation. I rate this a speculative punt and as ever if you are tempted please DYOR and remember you are responsible for your own buying and selling timing actions.
Innovative UK manufacturer of high tech screening and diagnostic systems for urological disorders.
Latest Business Organisational Update
FDA approval of the Portascan applied for and subsequently granted in
December 2003.
Distribution agreements put in place in important markets across the
world.
UK sales organisation rebuilt and refocused.
New product opportunities to complement and strengthen the existing
range identified.
Satisfactory progress with the development of the quantitative point of
care PSA diagnostic system.
Financials
Interims31/10/2003.
The operating margin in the period was 32% compared with 31% in the previous
year and the benefits of tight control of overheads resulted in expenditure of
590,000, - 115,000 less than in the comparable prior year period. In summary
therefore, the operating loss, after 174,000 amortisation of goodwill (231,000
in 2002), was 641,000 compared with 689,000 for the six months to 31st October
2002.
Cash on the books was 418,000 compared to 64,000 at the same time last year. With Sales increasing the position of the company gets stronger by the day.
Technical Products Update
A joint venture with two US corporations to develop the next generation
of the one-stop diagnostic system. This product should be launched in the second
half of 2004.
The development of a disposable product to assist control of
incontinence associated with prostate conditions. This will be available mid
2004.
The development of a compact specimen collection device for prostate
biopsies. This will be available mid 2004.
Preliminary plans to extend the portable bladder scanner range into
three other pathology areas.
Forward Outlook
A recovery in UK sales is
underway and negotiations with C R Bard for up to 9 other European countries
plus the Middle East to become party to the scanner supply agreement are
progressing. Export markets were a major focus for business development in the
period and distribution agreements were signed covering Japan, South East Asia
including Australasia. Negotiations are also in progress for sales
representation in India, Korea, China and Japan (for products not already included)
Jewel In The Crown
Most importantly however, access to the huge US market will have the
most significant impact on future sales and during the period FDA approval was
sought and recently received for the portable bladder scanner. Negotiations are
now at final stage with a large US distributor in relation to this and other
products of the Group.
CEO Philip Stimpson commented after the FDA approval for the portable bladder scanner, "the company is close to signing a distribution deal with a major International healthcare group"
Directors Buys
29 January 2004 ... The Company received notification today that
Philip Stimpson, Chief Executive Officer of the Company, bought 125,000
ordinary shares in the Company at a price of 8.03 pence each on 28 January 2004.
Kevin Middis, Finance Director,
bought 60,000 ordinary shares in the Company at a price of 8.03 pence each on 28
January 2004.
Omer Karim, Non-Executive Medical
Research Director, bought 475,000 ordinary shares in the Company at a price of
8.03 pence each on 28 January 2004.
A CLEAR SIGN THAT THE MANAGEMENT ARE VERY CONFIDENT OF THE COMPANYS FUTURE
Company Website
www.mediwatch.com
Summing up the shares are around 10.2p to buy and there are circa of 23.4 million in circulation. I rate this a speculative punt and as ever if you are tempted please DYOR and remember you are responsible for your own buying and selling timing actions.
cathbroadley - 20 Jul 2004 14:10 - 136 of 145
Only thing we have waited 7 months for news that was imminent back Januray
scotinvestor - 20 Jul 2004 16:06 - 137 of 145
yeah cath, its pathetic but i'm still holding. bit of a medium term hold for me this one
Oakapples142
- 20 Jul 2004 17:14
- 138 of 145
It has even got me buying more -topped up at 6.02 to-day - based on the rather romantic idea that it cuts my loss overall
Happy1 - 20 Jul 2004 17:41 - 139 of 145
To be able to BUY under the placing price is an offer not to be missed.
Oakapples142
- 21 Jul 2004 08:44
- 140 of 145
"Quote me Happy" 8% up - now how about an announcement -
Happy1 - 21 Jul 2004 09:55 - 141 of 145
Stock is very illiquid so relatively low buying volumes drives the price up.
Happy1 - 21 Jul 2004 09:56 - 142 of 145
Also looks like a double bottom on the chart ;-)
scotinvestor - 21 Jul 2004 12:59 - 143 of 145
this is rocketing today. at last!
SueHelen
- 21 Jul 2004 14:44
- 144 of 145
Interesting, 450,000 T BUY (Single protected purchase) reported at 7.68 pence.
Happy1 - 24 Aug 2004 21:15 - 145 of 145
At 6.5p to buy this certainly looks like we are back in the buy and hold scenario.
The anticipated news still has not materialised but when it does watch for the big rise.
The anticipated news still has not materialised but when it does watch for the big rise.
| About MoneyAM | Ts and Cs | Privacy Policy | Investment Warning | Content Standards | Corporate Solutions | Advertise With Us | Site Map | © 2025 MoneyAM |
Register now for FREE
Share Prices,
Stock Quotes,
Charts, Bulletin Boards, Indices, Watchlists, Portfolio, Market News, Research
or see our Premium Services including Level 2, Terminal and much more.
Follow us on Twitter